Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis

NCT01365793 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1389

Enrollment

OTHER

Sponsor class

Conditions

Cerebral Edema
Diabetic Ketoacidosis

Interventions

DRUG: 0.45% saline replacement fluid
DRUG: 0.9% saline replacement fluid
DRUG: 0.45% saline intravenous fluid
DRUG: 0.9% saline Intravenous fluid

Sponsor

University of California, Davis

Collaborators

[object Object]